BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

26 hedge funds and large institutions have $4.65M invested in BRAINSTORM CELL THERAPUTC in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
-1
Holders Change %
-3.7%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
4
Closed
3
Calls
$335K
Puts
$8K
Net Calls
+$327K
Net Calls Change
+$317K

Top Buyers

1
BlackRock
1
BlackRock
New York
$327K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.72M
3
Citadel Advisors
3
Citadel Advisors
Florida
$74K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$311K
5
Northern Trust
5
Northern Trust
Illinois
$145K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
SM
2
Sabby Management
Florida
$296K
3
SEI Investments
3
SEI Investments
Pennsylvania
$0
4
Creative Planning
4
Creative Planning
Kansas
$0
5
AIM
5
Acrospire Investment Management
Illinois
$15K
Name Holding Trade Value Shares
Change 		Shares
Change %
US Bancorp
26
US Bancorp
Minnesota
$1K – – –
PA
27
Perceptive Advisors
New York
– -$1.02M -26,667 Closed
SEI Investments
28
SEI Investments
Pennsylvania
– -$16K -420 Closed
Creative Planning
29
Creative Planning
Kansas
– -$3K -67 Closed
1
2